Deadline Alert: Compass, Inc. Stockholders Face December 8, 2026 Lead Plaintiff Deadline in Securities Fraud Class Action, The Law Offices of Howard G. Smith Highlights

Deadline Alert: Compass, Inc. Stockholders Face December 8, 2026 Lead Plaintiff Deadline in Securities Fraud Class Action, The Law Offices of Howard G. Smith Highlights BENSALEM, Pa.--( BUSINESS WIRE)--Compass, Inc. ("Compass" or the "Company") (NYSE: COMP) investors who wish to serve as lead plaintiff in a pending securities fraud class action lawsuit must move the Court by December 8, 2026. The suit was filed on behalf of investors who purchased or otherwise acquired the Company's securities from January 9, 2026 through October 7, 2026, inclusive. The Law Offices of Howard G. Smith today highlighted the deadline in the case, Magloire v. Compass, Inc. et al., which was filed on October 7, 2026 in the U.S. District Court Southern District of New York (Case No. 1:26-cv-08885).

Investors with losses on Compass, Inc. securities can reach The Law Offices of Howard G. Smith about the Compass, Inc. lawsuit before the December 8, 2026 deadline to discuss potential claims under the federal securities laws.

Key deadline for Compass, Inc. investors

What happened?

On January 9, 2026, Compass officially acquired and merged with Anywhere Real Estate.

Then, on February 19, 2026, eighteen members of Congress sent a letter to then-Attorney General Pamela Bondi, requesting information regarding the Department of Justice’s review of the merger and criticizing the “deeply disturbing” “fact pattern reported in the Compass-Anywhere deal” regarding paid-for “access to high-level Trump Administration DOJ officials[.]”

Then, in June 2026, the New York State Attorney General confirmed the existence of an antitrust investigation into Compass regarding the merger.

Following these events, the price of Compass stock traded as low as $9.19 per share, a decline of over 28% from the approximately $12.84 share price on the exchange date for the merger.

Allegations in the Compass, Inc. case

The Compass, Inc. shareholder lawsuit alleges that, throughout the class period, defendants made materially false and/or misleading statements and failed to disclose material adverse facts about Compass, Inc.'s business, operations, and prospects. Specifically, the complaint alleges defendants failed to disclose to investors that: (1) Compass and Anywhere failed to “use their respective reasonable best efforts to obtain [] authorizations and consents” from “certain regulatory authorities” and “to take, or cause to be taken, all appropriate actions and . . . all things necessary, proper or advisable under applicable law (including any antitrust laws) to consummate and make effective the merger at the earliest practicable date”; (2) Compass was not in “compliance with applicable laws,” with “the absence of governmental investigations and the possession of and compliance with licenses and permits necessary for the conduct of business.”; (3) Defendants hired a well-connected lobbyist and lawyer to obtain access to high-level Department of Justice officials to circumvent the antitrust merger review process; and (4) as a result, defendants' positive statements about Compass, Inc.'s business, operations, and prospects were materially misleading and/or lacked a reasonable basis at all relevant times.

Compass, Inc. investors who purchased or otherwise acquired securities during the class period may move the Court by December 8, 2026 to seek appointment as lead plaintiff in this putative class action.

"The lawsuit against Compass, Inc. alleges that, among other things, the Company failed to tell investors that Compass and Anywhere failed to “use their respective reasonable best efforts to obtain [] authorizations and consents” from “certain regulatory authorities” and “to take, or cause to be taken, all appropriate actions and . . . all things necessary, proper or advisable under applicable law (including any antitrust laws) to consummate and make effective the merger at the earliest practicable date”. Compass, Inc. investors who bought during the class period may want to know their options before the December 8, 2026 lead plaintiff deadline passes," said Howard G. Smith of The Law Offices of Howard G. Smith.

Next steps for Compass, Inc. investors

Compass, Inc. investors who suffered losses may contact The Law Offices of Howard G. Smith to learn about pursuing their claims. Lead plaintiff motions in the Compass, Inc. class action are due to the Court by December 8, 2026. For more information, visit the firm's website, email howardsmith@howardsmithlaw.com, or call (215) 638-4847.

To be a member of the Compass, Inc. class, you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent class member. No class has been certified so far in the Compass, Inc. case.

Common questions from Compass, Inc. investors

Who is eligible? Investors who acquired Compass, Inc. securities from January 9, 2026 through October 7, 2026 and suffered losses may qualify for the class in the Compass, Inc. shareholder lawsuit.

What is the deadline? Lead plaintiff motions in the Compass, Inc. case are due by December 8, 2026.

Can I still be part of the Compass, Inc. class after the deadline? Yes, Compass, Inc. investors who do not seek lead plaintiff appointment may remain class members.

Does it cost anything? The Law Offices of Howard G. Smith works on contingency, so investors pay no attorneys' fees unless there is a recovery, and any fees require court approval.

About The Law Offices of Howard G. Smith

The Law Offices of Howard G. Smith has helped injured investors recover their money for more than 15 years. The firm prosecutes securities fraud, takeover, and derivative litigation against public companies and their officers, directors, and advisors in federal and state courts nationwide, and has helped clients recover hundreds of millions of dollars in losses. Clients speak directly with a lawyer, who will promptly answer any question.

Prior results do not guarantee a similar outcome.